Source:http://linkedlifedata.com/resource/pubmed/id/11442483
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-7-9
|
pubmed:abstractText |
While it has been established that anti-phospholipid antibodies (aPL) are associated with recurrent miscarriage (RM), the importance of anti-beta2 glycoprotein 1 (GP1) IgG and anti-annexin V IgG antibodies as risk factors for RM is undefined. We have investigated the prevalence of anti-beta2 GP1 IgG and anti-annexin V IgG antibodies in 54 aPL-positive and 48 aPL-negative women with RM. The prevalence of IgG anti-beta2 GP1 antibodies was not significantly different in persistently aPL-positive women with RM (7%), aPL-negative women with RM (6%) and the normal parous control group (3%). Anti-annexin V IgG antibody prevalence was significantly increased in aPL-positive women with RM compared with aPL-negative women with RM (P = 0.01). The elevations were found in 35%, 19% and 16% of aPL-positive women with RM, aPL-negative women with RM and the control group respectively. No women showed positivity for both anti-beta2 GP1 IgG and anti-annexin V antibodies. Anti-beta2 GP1 IgG antibodies do not appear to be contributory to the investigation of women with RM. Anti-annexin V antibody positivity, although associated with aPL positivity in women with RM, is not an independent risk marker.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Annexin A5,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antiphospholipid,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Lupus Coagulation Inhibitor,
http://linkedlifedata.com/resource/pubmed/chemical/Pregnancy-Specific beta...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
911-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11442483-Abortion, Habitual,
pubmed-meshheading:11442483-Adult,
pubmed-meshheading:11442483-Annexin A5,
pubmed-meshheading:11442483-Antibodies, Antiphospholipid,
pubmed-meshheading:11442483-Autoantibodies,
pubmed-meshheading:11442483-Case-Control Studies,
pubmed-meshheading:11442483-Chi-Square Distribution,
pubmed-meshheading:11442483-Female,
pubmed-meshheading:11442483-Humans,
pubmed-meshheading:11442483-Immunoglobulin G,
pubmed-meshheading:11442483-Lupus Coagulation Inhibitor,
pubmed-meshheading:11442483-Middle Aged,
pubmed-meshheading:11442483-Pregnancy,
pubmed-meshheading:11442483-Pregnancy-Specific beta 1-Glycoproteins
|
pubmed:year |
2001
|
pubmed:articleTitle |
Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage.
|
pubmed:affiliation |
Department of Haematology, St Mary's Hospital, University College London Hospitals NHS Trust, London, UK.
|
pubmed:publicationType |
Journal Article
|